CA
INSIDER · RAPP · Rapport Therapeutics, Inc. · CHIEF EXECUTIVE OFFICER
Ceesay Abraham
Every open-market transaction filed under this name, Aug 25 to Oct 7.
Filings
8
0 buys · 8 sells
Bought
—
open market, at cost
Sold
$1.5M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 7 | RAPP | Rapport Therapeutics, Inc. | Chief Executive Officer | Sell | 1,147 | $30.66 | $35K | −7.6% |
| Oct 6 | RAPP | Rapport Therapeutics, Inc. | Chief Executive Officer | Sell | 3,375 | $32.03 | $108K | −11.6% |
| Sep 23 | RAPP | Rapport Therapeutics, Inc. | Chief Executive Officer | Sell | 43 | $41.05 | $2K | −31.0% |
| Sep 23 | RAPP | Rapport Therapeutics, Inc. | Chief Executive Officer | Sell | 215 | $39.86 | $9K | −28.9% |
| Sep 23 | RAPP | Rapport Therapeutics, Inc. | Chief Executive Officer | Sell | 1,952 | $39.05 | $76K | −27.5% |
| Sep 8 | RAPP | Rapport Therapeutics, Inc. | Chief Executive Officer | Sell | 1,069 | $46.01 | $49K | −38.4% |
| Sep 8 | RAPP | Rapport Therapeutics, Inc. | Chief Executive Officer | Sell | 7,141 | $45.55 | $325K | −37.8% |
| Aug 25 | RAPP | Rapport Therapeutics, Inc. | Chief Executive Officer | Sell | 18,921 | $49.57 | $938K | −42.9% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.